Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sexual dysfunction caused by reboxetine.

E M Haberfellner1

  • 1e.m.haberfellner@aon.at

Pharmacopsychiatry
|April 16, 2002
PubMed
Summary
This summary is machine-generated.

Reboxetine medication can cause sexual dysfunction, including prolonged, less intense orgasms and post-defecation seminal emissions. These side effects, accompanied by pain, resolved after stopping the drug.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Medical rehabilitation of patients with mental or psychosomatic disorders in austria--findings of a catamnestic study].

Die Rehabilitation·2008
Same author

A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials.

Pharmacopsychiatry·2007
Same author

Priapism with sertraline-risperidone combination.

Pharmacopsychiatry·2007
Same author

[Patient knowledge regarding tardive dyskinesia].

Der Nervenarzt·2006
Same author

Spontaneous remission of SSRI-induced orgasm delay.

Pharmacopsychiatry·2004
Same author

Myoclonic and generalized tonic clonic seizures during combined treatment with low doses of clozapine and haloperidol.

European psychiatry : the journal of the Association of European Psychiatrists·2002

Area of Science:

  • Pharmacology
  • Neuroscience
  • Sexual Medicine

Background:

  • Reboxetine is a selective norepinephrine reuptake inhibitor used for treating depression.
  • Sexual dysfunction is a common side effect of antidepressant medications.
  • Understanding drug-induced sexual dysfunction is crucial for patient care.

Observation:

  • The author self-experienced prolonged orgasm of reduced intensity.
  • Seminal emission after defecation was also observed.
  • Both conditions were associated with pain.

Findings:

  • Reboxetine was identified as the cause of the sexual dysfunction.
  • Symptoms resolved within two days of discontinuing reboxetine.
  • This suggests a direct causal link between reboxetine and the observed sexual side effects.

Related Experiment Videos

Implications:

  • Highlights the potential for reboxetine to cause specific sexual side effects.
  • Emphasizes the importance of patient reporting of adverse drug reactions.
  • Informs clinical practice regarding the management of reboxetine-related sexual dysfunction.